Search

Your search keyword '"Aljuhani, Ohoud"' showing total 316 results
Start Over Author "Aljuhani, Ohoud"
316 results on '"Aljuhani, Ohoud"'

51. Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Alnajjar, Lina I., additional, Altebainawi, Ali F., additional, AlFaifi, Mashael, additional, Vishwakarma, Ramesh, additional, Alenazi, Abeer A., additional, Alalawi, Mai, additional, Alissa, Abdulrahman, additional, Alsowaida, Yazed S., additional, Alsohimi, Samiah, additional, Almagthali, Alaa, additional, Alay, Saeed M., additional, Altaher, Noora, additional, Alamri, Mohammed G., additional, Alangari, Dalal, additional, Alzahrani, Amer, additional, Abdul Razack, Habeeb Ibrahim, additional, Alhamoud, Jwael, additional, Alshaya, Abdulrahman, additional, Gramish, Jawaher, additional, Al Aamer, Kholoud, additional, Alsaeedi, Alawi S., additional, and Alghamdi, Ghassan, additional

Published
2023
Full Text
View/download PDF

52. Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis

Author

Hafiz, Awatif, primary, Alkofide, Hadeel, additional, Al Sulaiman, Khalid, additional, Joharji, Hala, additional, Aljohani, Sarah, additional, Sarkhi, Khadijah A., additional, Alharbi, Reem, additional, Korayem, Ghazwa B., additional, AlFaifi, Mashael, additional, Alsohimi, Samiah, additional, and Aljuhani, Ohoud, additional

Published
2023
Full Text
View/download PDF

53. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Vishwakarma, Ramesh, additional, AlFaifi, Mashael, additional, Alsohimi, Samiah, additional, Alrayes, Aljoharah, additional, Albishi, Sara, additional, Alqahtani, Reem, additional, Alalawi, Mai, additional, Al Sulaihim, Ibrahim, additional, Alanazi, Thamer A., additional, Alqahtani, Rahaf A., additional, Almagthali, Alaa, additional, Jomah, Shahamah, additional, Alshlowi, Areej, additional, Alshammari, Tahani R., additional, Alzahrani, Shahad S., additional, and Abdulqader, Marwa I., additional

Published
2023
Full Text
View/download PDF

54. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study – New-Onset Atrial Fibrillation and COVID-19

Author

Kensara, Raed, primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B, additional, Alkofide, Hadeel, additional, Almohareb, Sumaya N, additional, Alosaimi, Yousef S, additional, Altebainawi, Ali F, additional, Bin saleh, Khalid, additional, Andas, Norah Al, additional, Harbi, Shmeylan Al, additional, Harthi, Abdullah F Al, additional, Ashkan, Uhood, additional, Alghamdi, Rema, additional, Badreldin, Hisham A, additional, Hafiz, Awatif, additional, AlFaifi, Mashael, additional, Alqahtani, Rahaf A, additional, Vishwakarma, Ramesh, additional, Alenazi, Abeer A, additional, Alalawi, Mai, additional, mahboob, Reem, additional, Alfouzan, Renad A, additional, Al Tuhayni, Layan B, additional, Qahtani, Nouf Al, additional, and Sulaiman, Khalid Al, additional

Published
2023
Full Text
View/download PDF

55. The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Alhammad, Abdullah M., additional, Al Aamer, Kholoud, additional, Alshehri, Sara, additional, Alhuwahmel, Abdulmohsen, additional, Kharbosh, Abdullah, additional, Alshehri, Areej, additional, Alshareef, Hanan, additional, Al Sulaihim, Ibrahim, additional, Alghamdi, Albandari, additional, Al Harbi, Shmeylan, additional, Vishwakarma, Ramesh, additional, Alabdan, Numan, additional, Alrajhi, Yousef, additional, Al Katheri, Abdulmalik, additional, Alenazi, Abeer A., additional, Alalawi, Mai, additional, and Al Ghamdi, Ghassan, additional

Published
2022
Full Text
View/download PDF

56. The Role of Critical Care Pharmacists Beyond Intensive Care Units: A Narrative Review on Medication Management for ICU Survivors

Author

Aljuhani, Ohoud

Subjects
Critical care, Intensive care units, Pharmacist, Medication Management, Follow-up clinic
Abstract

There is a global improvement in critical care services that leads to prolonged survival after ICU stay. This improvement has increased the demand for multidisciplinary critical care services beyond the ICU. Recently, efforts focused on the patient’s quality of life after ICU discharge and family involvement in their care. Most older adults who survive an ICU stay are challenged by complex medication changes following discharge, as are their caregivers. Limited literature addresses the standard of practice for medication management and critical care pharmacists’ involvement in post-ICU services. This narrative review describes the available literature that addresses medication management in post-ICU settings by critical care pharmacists and potential axes for future research. The included articles were articles published in English related to adult ICU survivors and addressed pharmacist involvement or medication management. The main findings summarize the most performed pharmacist services following ICU discharge, including medication reconciliation, full medication review, and adverse drug event preventative measures. This review concluded a lack of consensus about the standard model of post-ICU pharmacy services and the relationship of these services with long-term outcomes.

Published
2023

57. sj-pdf-1-jpp-10.1177_08971900211038363 – Supplemental Material for Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study

Author

Al Sulaiman, Khalid, Kharbosh, Abdullah, Bin Salah, Khalid, Alsulaiman, Thamer, Al Andas, Norah, Aljuhani, Ohoud, and Vishwakarma, Ramesh

Subjects
FOS: Clinical medicine, 111199 Nutrition and Dietetics not elsewhere classified, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, sj-pdf-1-jpp-10.1177_08971900211038363 for Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study by Khalid Al Sulaiman, Abdullah Kharbosh, Khalid Bin Salah, Thamer Alsulaiman, Norah Al Andas, Ohoud Aljuhani and Ramesh Vishwakarma in Journal of Pharmacy Practice

Published
2023
Full Text
View/download PDF

58. sj-docx-1-jic-10.1177_08850666221150886 - Supplemental material for Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study

Author

Aljuhani, Ohoud, Korayem, Ghazwa B., Altebainawi, Ali F., Al Harthi, Abdullah, Badreldin, Hisham A., Alsalloum, Muath A., Eljaaly, Khalid, Alharbi, Aisha, Aljehani, Rowina, Vishwakarma, Ramesh, Alenazi, Abeer A., Alalawi, Mai, Alissa, Abdulrahman, Al Aamer, Kholoud, Al Enazi, Huda, Almusallam, Mohammed, Alshehri, Abdulaziz, Bukhari, Rawan, Alasmari, Ghaday, AlQahtani, Maha M., Al Shammari, Sultanah, Alsulaymi, Hatim O., and Al Sulaiman, Khalid

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110305 Emergency Medicine
Abstract

Supplemental material, sj-docx-1-jic-10.1177_08850666221150886 for Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study by Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, Hisham A. Badreldin, Muath A. Alsalloum, Khalid Eljaaly, Aisha Alharbi, Rowina Aljehani, Ramesh Vishwakarma, Abeer A. Alenazi, Mai Alalawi, Abdulrahman Alissa, Kholoud Al Aamer, Huda Al Enazi, Mohammed Almusallam, Abdulaziz Alshehri, Rawan Bukhari, Ghaday Alasmari, Maha M. AlQahtani, Sultanah Al Shammari, Hatim O. Alsulaymi and Khalid Al Sulaiman in Journal of Intensive Care Medicine

Published
2023
Full Text
View/download PDF

59. sj-docx-1-cat-10.1177_10760296231177017 - Supplemental material for Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

Author

Al Sulaiman, Khalid, Aljuhani, Ohoud, Korayem, Ghazwa B., Alnajjar, Lina I., Altebainawi, Ali F., AlFaifi, Mashael, Vishwakarma, Ramesh, Alenazi, Abeer A., Alalawi, Mai, Alissa, Abdulrahman, Alsowaida, Yazed S., Alsohimi, Samiah, Almagthali, Alaa, Alay, Saeed M., Altaher, Noora, Alamri, Mohammed G., Alangari, Dalal, Alzahrani, Amer, Abdul Razack, Habeeb Ibrahim, Alhamoud, Jwael, Alshaya, Abdulrahman, Gramish, Jawaher, Al Aamer, Kholoud, Alsaeedi, Alawi S., and Alghamdi, Ghassan

Subjects
FOS: Clinical medicine, Cardiology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, sj-docx-1-cat-10.1177_10760296231177017 for Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study by Khalid Al Sulaiman, MBA, BCCCP, BCNSP, FCCM, Ohoud Aljuhani, PharmD, Ghazwa B. Korayem, PharmD, Lina I. Alnajjar, PharmD, Ali F. Altebainawi, PharmD, Mashael AlFaifi, PharmD, Ramesh Vishwakarma, PhD, Abeer A. Alenazi, PharmD, Mai Alalawi, PharmD, Abdulrahman Alissa, PharmD, Yazed S. Alsowaida, BSc, PharmD, Samiah Alsohimi, PharmD, Alaa Almagthali, PharmD, Saeed M. Alay, PharmD, Noora Altaher, PharmD, Mohammed G. Alamri, PharmD, Dalal Alangari, PharmD, Amer Alzahrani, MD, Habeeb Ibrahim Abdul Razack, MPharm, MSc CRRA, Jwael Alhamoud, BSc, Abdulrahman Alshaya, PharmD, Jawaher Gramish, PharmD, Kholoud Al Aamer, MSc, Alawi S. Alsaeedi, MD, and Ghassan Alghamdi, MD in Clinical and Applied Thrombosis/Hemostasis

Published
2023
Full Text
View/download PDF

60. sj-docx-1-cat-10.1177_10760296231156178 - Supplemental material for Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study – New-Onset Atrial Fibrillation and COVID-19

Author

Kensara, Raed, Aljuhani, Ohoud, Korayem, Ghazwa B, Alkofide, Hadeel, Almohareb, Sumaya N, Alosaimi, Yousef S, Altebainawi, Ali F, Bin saleh, Khalid, Andas, Norah Al, Harbi, Shmeylan Al, Harthi, Abdullah F Al, Ashkan, Uhood, Alghamdi, Rema, Badreldin, Hisham A, Hafiz, Awatif, AlFaifi, Mashael, Alqahtani, Rahaf A, Vishwakarma, Ramesh, Alenazi, Abeer A, Alalawi, Mai, mahboob, Reem, Alfouzan, Renad A, Al Tuhayni, Layan B, Qahtani, Nouf Al, and Sulaiman, Khalid Al

Subjects
FOS: Clinical medicine, Cardiology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental material, sj-docx-1-cat-10.1177_10760296231156178 for Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study – New-Onset Atrial Fibrillation and COVID-19 by Raed Kensara, Ohoud Aljuhani, Ghazwa B Korayem, Hadeel Alkofide, Sumaya N Almohareb, Yousef S Alosaimi and Ali F Altebainawi, Khalid Bin saleh, Norah Al Andas, Shmeylan Al Harbi, Abdullah F Al Harthi, Uhood Ashkan, Rema Alghamdi, Hisham A Badreldin, Awatif Hafiz, Mashael AlFaifi, Rahaf A Alqahtani, Ramesh Vishwakarma, Abeer A Alenazi, Mai Alalawi, Reem mahboob, Renad A Alfouzan, Layan B Al Tuhayni, Nouf Al Qahtani, Khalid Al Sulaiman in Clinical and Applied Thrombosis/Hemostasis

Published
2023
Full Text
View/download PDF

62. Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study.

Author

Al Sulaiman, Khalid, Kharbosh, Abdullah, Bin Salah, Khalid, Alsulaiman, Thamer, Al Andas, Norah, Aljuhani, Ohoud, and Vishwakarma, Ramesh

Subjects
INTENSIVE care units, LENGTH of stay in hospitals, VASOCONSTRICTORS, CRITICALLY ill, PATIENTS, RETROSPECTIVE studies, SEPSIS, TREATMENT effectiveness, SEVERITY of illness index, HOSPITAL mortality, ARTIFICIAL respiration, BILE acids, CRITICAL care medicine, GLASGOW Coma Scale, DESCRIPTIVE statistics, SEPTIC shock, CARDIOTONIC agents
Abstract

Background: Using ursodeoxycholic acid (UDCA) in critically ill patients as adjunctive therapy for sepsis/septic shock in neonates and children is controversial, while it has not been extensively investigated in adults. This study aims to assess the effect of UDCA use on the early resolution of sepsis/septic shock in critically ill adult patients. Method: A retrospective study of critically ill adult patients in the intensive care unit (ICU) admitted with sepsis/septic shock at King Abdulaziz Medical City. Based on their usage of UDCA, patients were categorized into two groups. A total of 88 patients were included for analysis after matching, based on severity of illness scores within 24-hours of ICU admission. The primary outcome was to assess the effect of UDCA on the severity and resolution of shock at day three of ICU admission. The secondary outcomes were 30-day in-hospital mortality, mechanical ventilation (MV) duration, and ICU length of stay (LOS). Results: Out of the 88 patients matched, 44 patients (50%) received UDCA during the study period. Using UDCA was neither associated with improvement in Sequential Organ Failure Assessment (SOFA) score (p -value: 0.32), inotropes/vasopressors requirement (p -value: 0.79), Glasgow Coma Scale (GCS) (p -value: 0.59) nor total bilirubin levels (p -value: 0.79) at day three compared with the control. There was a significant association between using UDCA and improvement in PaO2/FiO2 ratio (p -value: 0.01) and early extubation at day three (p -value: 0.04). Conclusion: Using UDCA in critically ill patients with sepsis/septic shock was not associated with improvement in shock severity and resolution. However, patients who received UDCA were more likely to be extubated and not require MV on day three of ICU admission. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

63. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Al Harbi, Shmeylan, additional, Al Shaya, Abdulrahman, additional, Badreldin, Hisham A., additional, Kensara, Raed, additional, Alharthi, Abdullah F., additional, Alghamdi, Jahad, additional, Alawad, Ahad, additional, Alotaibi, Rand, additional, Kharbosh, Abdullah, additional, Al Muqati, Hessa, additional, Alhuwahmel, Abdulmohsen, additional, Almusallam, Mohammed, additional, Albarrak, Ghada, additional, Al Sulaihim, Ibrahim, additional, Alanazi, Bader, additional, Al-Dosari, Bodoor S., additional, Vishwakarma, Ramesh, additional, Alsaeedi, Alawi S., additional, Al Ghamdi, Ghassan, additional, Alkofide, Hadeel, additional, and Al-Dorzi, Hasan M., additional

Published
2022
Full Text
View/download PDF

64. Vitamin D serum level predicts stroke clinical severity, functional independence, and disability—A retrospective cohort study

Author

Alharbi, Abdullah R., primary, Alali, Amer S., additional, Samman, Yahya, additional, Alghamdi, Nouf A., additional, Albaradie, Omar, additional, Almaghrabi, Maan, additional, Makkawi, Seraj, additional, Alghamdi, Saeed, additional, Alzahrani, Mohammad S., additional, Alsalmi, Mohammed, additional, Karamyan, Vardan T., additional, Al Sulaiman, Khalid, additional, Aljuhani, Ohoud, additional, and Alamri, Faisal F., additional

Published
2022
Full Text
View/download PDF

65. The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study

Author

Sulaiman, Khalid Al, primary, Al Qahtani, Nouf, additional, Al Muqrin, Mashael, additional, Al Dossari, Maram, additional, Al Wabel, Ali, additional, Al Sulaiman, Tareq, additional, Vishwakarma, Ramesh, additional, Alolayan, Abdulaziz, additional, Abudayah, Fatimah, additional, Korayem, Ghazwa B., additional, and Aljuhani, Ohoud, additional

Published
2022
Full Text
View/download PDF

66. Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional Study

Author

Badreldin, Hisham A., primary, Saleh, Khalid Bin, additional, Badr, Aisha F., additional, Alhifany, Abdullah, additional, Alowais, Shuroug A., additional, Almohareb, Sumaya N., additional, Alsuhebany, Nada, additional, Alshehri, Abdulmajeed, additional, Alzahrani, Mohammed, additional, Aldwsari, Anas, additional, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Sulaiman, Khalid Al, additional, Alturki, Allulu, additional, Alhaidal, Hayfa, additional, and Ghawaa, Yazeed, additional

Published
2022
Full Text
View/download PDF

68. Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature

Author

Al Sulaiman,Khalid, Alsuwayyid,Faisal, Alrashidi,Abdulrahman, Alhijris,Mohammed, Almutairi,Faisal, Alharthi,Fahad, Abu Esba,Laila Carolina, Aljuhani,Ohoud, Badreldin,Hisham A, Al Sulaiman,Khalid, Alsuwayyid,Faisal, Alrashidi,Abdulrahman, Alhijris,Mohammed, Almutairi,Faisal, Alharthi,Fahad, Abu Esba,Laila Carolina, Aljuhani,Ohoud, and Badreldin,Hisham A

Abstract

Khalid Al Sulaiman,1– 4 Faisal Alsuwayyid,2 Abdulrahman Alrashidi,2 Mohammed Alhijris,2 Faisal Almutairi,2 Fahad Alharthi,2 Laila Carolina Abu Esba,1– 3 Ohoud Aljuhani,4,5 Hisham A Badreldin1– 3 1Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; 2College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 3King Abdullah International Medical Research Center, Biostatistics and Bioinformatics Department, Riyadh, Saudi Arabia; 4Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh/Jeddah, Saudi Arabia; 5Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Khalid Al Sulaiman, King Abdulaziz Medical City (KAMC) - Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia, Email alsulaimankh@hotmail.comBackground: Historically, warfarin was the mainstay anticoagulant agent to manage patients presenting with thrombotic disorders caused by Protein C or S deficiency. Several direct oral anticoagulants (DOACs) were introduced over the past decade. They showed superiority over warfarin in patients with venous thromboembolism in many landmark trials. Insufficient data are available that examine the outcome of utilizing apixaban in patients with protein S deficiency induce thrombosis.Case(s) Presentation: We reported the clinical outcomes of utilizing apixaban in four patients with systemic thrombosis caused by protein C or S deficiency who presented to a tertiary hospital in Riyadh, Saudi Arabia. Four patients exhibited typical features of thrombotic events. After confirming the diagnosis, one patient was initially started on apixaban, and the other three patients were converted from warfarin to apixaban. Three of the four patients tolerated the apixaban during the follow-up period. Additionally, they did not have any bleeding or thrombotic complications. However, one patient developed recurrent thrombotic events des

Published
2022

70. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study

Author

Al Harthi, Abdullah F., primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Alenezi, Raghdah S., additional, Al Harbi, Shmeylan, additional, Gramish, Jawaher, additional, Kensara, Raed, additional, Hafidh, Awattif, additional, Al Enazi, Huda, additional, Alawad, Ahad, additional, Alotaibi, Rand, additional, Alshehri, Abdulaziz, additional, Alhuthaili, Omar, additional, Vishwakarma, Ramesh, additional, bin Saleh, Khalid, additional, Alsulaiman, Thamer, additional, Alqahtani, Rahaf Ali, additional, Hussain, Sajid, additional, Almazrou, Saja, additional, and Al Sulaiman, Khalid, additional

Published
2022
Full Text
View/download PDF

71. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study

Author

Aljuhani, Ohoud, primary, Al Sulaiman, Khalid, additional, Hafiz, Awatif, additional, Eljaaly, Khalid, additional, Alharbi, Aisha, additional, Algarni, Rahmah, additional, Al Homaid, Sarah, additional, Kahtani, Khawla, additional, Alsulaiman, Tareq, additional, Vishwakarma, Ramesh, additional, Al Ghamdi, Ghassan, additional, Alalawi, Mai, additional, and Korayem, Ghazwa B., additional

Published
2022
Full Text
View/download PDF

74. Additional file 1 of Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

Author

Al Sulaiman, Khalid, Korayem, Ghazwa B., Altebainawi, Ali F., Al Harbi, Shmeylan, Alissa, Abdulrahman, Alharthi, Abdullah, Kensara, Raed, Alfahed, Amjaad, Vishwakarma, Ramesh, Al Haji, Hussain, Almohaimid, Naif, Al Zumai, Omar, Alrubayan, Fahad, Asiri, Abdulmajid, Alkahtani, Nasser, Alolayan, Abdulaziz, Alsohimi, Samiah, Melibari, Nawal, Almagthali, Alaa, Aljahdali, Seba, Alenazi, Abeer A., Alsaeedi, Alawi S., Al Ghamdi, Ghassan, Al Faris, Omar, Alqahtani, Joud, Al Qahtani, Jalal, Alshammari, Khalid A., Alshammari, Khalil I., and Aljuhani, Ohoud

Abstract

Additional file 1. Outcomes definition(s).

Published
2022
Full Text
View/download PDF

77. Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature

Author

Al Sulaiman, Khalid, primary, Hafiz, Awatif, additional, Badreldin, Hisham A., additional, Korayem, Ghazwa B., additional, Alsuwayyid, Faisal, additional, Alrashidi, PharmD, Abdulrahman, additional, Alhijris, Mohammed, additional, Almutairi, PharmD, Faisal, additional, Alharthi, Fahad, additional, Alghamdi, Saad, additional, Abu Alreesh, Ahmed, additional, and Aljuhani, Ohoud, additional

Published
2022
Full Text
View/download PDF

81. Clinical pharmacist core competencies in Saudi Arabia: A position paper by the Saudi Society of Clinical Pharmacy

Author

Al-Jedai, Ahmed, primary, Badreldin, HishamA, additional, Aldemerdash, Ahmed, additional, Aljuhani, Ohoud, additional, Joharji, Hala, additional, Al-Omari, BedorA, additional, Korayem, GhazwaB, additional, Eljaaly, Khalid, additional, Almudaiheem, HajerY, additional, Alawagi, Mohammad, additional, Al-Mowaina, SaharM, additional, and Albekairy, AbdulkareemM, additional

Published
2022
Full Text
View/download PDF

82. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study

Author

Al Harbi, Shmeylan, primary, Kensara, Raed, additional, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Al Harthi, Abdullah, additional, Vishwakarma, Ramesh, additional, Alenazi, Alaa M., additional, Almutairi, Abdulmajed, additional, Alshaya, Omar, additional, Alraddadi, Sultan, additional, Al Sulaiman, Tareq, additional, Aldakkan, Latifah, additional, Mahboob, Reem, additional, Alaamer, Kholoud, additional, Alissa, Abdulrahman, additional, Hafiz, Awatif, additional, Aldhayyan, Nada, additional, Althewaibi, Sara, additional, Alenezi, Farhan, additional, Alkhotani, Nadeen Y., additional, Alghamdi, Sara A., additional, Alenazi, Abeer A., additional, and Al Sulaiman, Khalid, additional

Published
2022
Full Text
View/download PDF

83. Clinical pharmacist interventions in intensive care units during Hajj: A multicenter retrospective study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Al Harbi, Mahasen, additional, Thabit, AbrarK, additional, F Alharthi, Abdullah, additional, Aldardeer, Namareq, additional, Alenazi, AhmedO, additional, Alghamdi, Badr, additional, Alissa, Dema, additional, Almudaiheem, Hajer, additional, Alluwaymi, Wafa, additional, Almushaikah, Sahar, additional, Almustaneer, Rana, additional, Alshennawi, Mohammed, additional, and Al-jedai, Ahmed, additional

Published
2022
Full Text
View/download PDF

84. Critical care pharmacy program accreditation standards framework and core competencies in Saudi Arabia: An opinion paper by the SSCP critical care and emergency medicine pharmacy specialty network

Author

Alshaya, AbdulrahmanI, primary, Aljuhani, Ohoud, additional, Alghadeer, SultanMohammed, additional, Ismail, Nadia, additional, Alkhani, Nada, additional, Alharbi, Shmeylan, additional, Alenazi, AhmedO, additional, Almehizia, Rayd, additional, Alsulaiman, Khalid, additional, Aljabri, Ahmed, additional, Buksh, Hussain, additional, and Alhammad, AbdullahM, additional

Published
2022
Full Text
View/download PDF

86. Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

Author

Sulaiman, Khalid Al, primary, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Harbi, Shmeylan Al, additional, Shaya, Abdulrahman Al, additional, Badreldin, Hisham A., additional, Kensara, Raed, additional, Harthi, Abdullah Al, additional, Alghamdi, Jahad, additional, Alawad, Ahad, additional, Alotaibi, Rand, additional, Kharbosh, Abdullah, additional, Muqati, Hessa Al, additional, Alhuwahmel, Abdulmohsen, additional, Almusallam, Mohammed, additional, Albarrak, Ghada, additional, Sulaihim, Ibrahim Al, additional, Alanazi, Bader, additional, Al-Dosari, Bodoor S., additional, Vishwakarma, Ramesh, additional, Alsaeedi, Alawi S., additional, Ghamdi, Ghassan Al, additional, and Al-Dorzi, Hasan M, additional

Published
2021
Full Text
View/download PDF

88. Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Bin Salah, Khalid, additional, Korayem, Ghazwa B., additional, Eljaaly, Khalid, additional, Al Essa, Mohammed, additional, Kharbosh, Abdullah, additional, Al Harbi, Feras, additional, Abuzaid, Maram, additional, Al Bilal, Sarah, additional, Almagthali, Alaa, additional, Alsohemi, Samia, additional, Alshabasy, Adel, additional, Noureldeen, Haytham, additional, Aboudeif, Mohammed, additional, Alshehri, Asma, additional, and Vishwakarma, Ramesh, additional

Published
2021
Full Text
View/download PDF

89. Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with COVID-19: A Multicenter Cohort Study.

Author

Kensara, Raed, Aljuhani, Ohoud, Korayem, Ghazwa B, Alkofide, Hadeel, Almohareb, Sumaya N, Alosaimi, Yousef S, Altebainawi, Ali F, Bin saleh, Khalid, Andas, Norah Al, Harbi, Shmeylan Al, Harthi, Abdullah F Al, Ashkan, Uhood, Alghamdi, Rema, Badreldin, Hisham A, Hafiz, Awatif, AlFaifi, Mashael, Alqahtani, Rahaf A, Vishwakarma, Ramesh, Alenazi, Abeer A, and Alalawi, Mai

Subjects
COVID-19, ATRIAL fibrillation, CRITICALLY ill, COHORT analysis, HOSPITAL mortality
Abstract

Atrial fibrillation (Afib) can contribute to a significant increase in mortality and morbidity in critically ill patients. Thus, our study aims to investigate the incidence and clinical outcomes associated with the new-onset Afib in critically ill patients with COVID-19. A multicenter, retrospective cohort study includes critically ill adult patients with COVID-19 admitted to the intensive care units (ICUs) from March, 2020 to July, 2021. Patients were categorized into two groups (new-onset Afib vs control). The primary outcome was the inhospital mortality. Other outcomes were secondary, such as mechanical ventilation (MV) duration, 30-day mortality, ICU length of stay (LOS), hospital LOS, and complications during stay. After propensity score matching (3:1 ratio), 400 patients were included in the final analysis. Patients who developed new-onset Afib had higher odds of in-hospital mortality (OR 2.76; 95% CI: 1.49-5.11, P = .001). However, there was no significant differences in the 30-day mortality. The MV duration, ICU LOS, and hospital LOS were longer in patients who developed new-onset Afib (beta coefficient 0.52; 95% CI: 0.28-0.77; P < .0001,beta coefficient 0.29; 95% CI: 0.12-0.46; P < .001, and beta coefficient 0.35; 95% CI: 0.18-0.52; P<.0001; respectively). Moreover, the control group had significantly lower odds of major bleeding, liver injury, and respiratory failure that required MV. New-onset Afib is a common complication among critically ill patients with COVID-19 that might be associated with poor clinical outcomes; further studies are needed to confirm these findings. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

90. Early Dexamethasone Use as A Protective Measure In Non-Mechanically Ventilated Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

Author

Sulaiman, Khalid Al, primary, Korayem, Ghazwa B., additional, Eljaaly, Khalid, additional, Altebainawi, Ali F., additional, Harbi, Omar Al, additional, Badreldin, Hisham A., additional, Harthi, Abdullah Al, additional, Yousif, Ghada Al, additional, Vishwakarma, Ramesh, additional, Albelwi, Shorouq, additional, Almutairi, Rahaf, additional, Almousa, Maha, additional, Alghamdi, Razan, additional, Alhubaishi, Alaa, additional, Alissa, Abdulrahman, additional, Alharbi, Aisha, additional, Algarni, Rahmah, additional, Homaid, Sarah Al, additional, Kahtani, Khawla, additional, Akhani, Nada, additional, Atassi, Abdulaleam Al, additional, Ghamdi, Ghassan Al, additional, and Aljuhani, Ohoud, additional

Published
2021
Full Text
View/download PDF

91. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

Author

Al Sulaiman, Khalid, primary, Aljuhani, Ohoud, additional, Al Aamer, Kholoud, additional, Al Shaya, Omar, additional, Al Shaya, Abdulrahman, additional, Alsaeedi, Alawi S., additional, Alhubaishi, Alaa, additional, Altebainawi, Ali F., additional, Al Harthi, Alaa, additional, Albelwi, Shorouq, additional, Almutairi, Rahaf, additional, Alsubaie, Norah, additional, Alsallum, Alanoud, additional, Korayem, Ghazwa B., additional, Alfahed, Amjaad, additional, Kensara, Raed, additional, Altebainawi, Elaf F., additional, Alenezi, Raghdah S., additional, Alsulaiman, Thamer, additional, Al Enazi, Huda, additional, Vishwakarma, Ramesh, additional, Al Dabbagh, Tarek, additional, Bakhsh, Umar, additional, and Al Ghamdi, Ghassan, additional

Published
2021
Full Text
View/download PDF

92. Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy

Author

Korayem, Ghazwa B., primary, Badreldin, Hisham A., additional, Eljaaly, Khalid, additional, Aldemerdash, Ahmed, additional, Al-Suhaibani, Lujain K., additional, Joharji, Hala, additional, Aljuhani, Ohoud, additional, Al-Omari, Bedor A., additional, Almudaiheem, Hajer Y., additional, Alhifany, Abdullah A., additional, Alawagi, Mohammad, additional, Al-Mowaina, Sahar M., additional, Al-Jazairi, Abdulrazaq S., additional, Albekairy, Abdulkareem M., additional, and Al-Jedai, Ahmed, additional

Published
2021
Full Text
View/download PDF

95. Evaluation of low-dose aspirin use among COVID-19 critically ill patients: A Multicenter Propensity Score Matched Study

Author

Harthi, Abdullah Al, primary, Sulaiman, Khalid Al, additional, Aljuhani, Ohoud, additional, Korayem, Ghazwa B., additional, Altebainawi, Ali F., additional, Alenezi, Raghdah S., additional, Harbi, Shmeylan Al, additional, Gramish, Jawaher, additional, Kensara, Raed, additional, Hafidh, Awattif, additional, Enazi, Huda Al, additional, Alawad, Ahad, additional, Alotaibi, Rand, additional, Alshehri, Abdulaziz, additional, Alhuthaili, Omar, additional, Vishwakarma, Ramesh, additional, Saleh, Khalid bin, additional, Alsulaiman, Thamer, additional, Alqahtani, Rahaf Ali, additional, Almazrou, Saja, additional, and Hussain, Sajid, additional

Published
2021
Full Text
View/download PDF

97. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study

Author

Saleh, Khalid Bin, primary, Hafiz, Awattif, additional, Alsulaiman, Khalid, additional, Aljuhani, Ohoud, additional, Alharbi, Shmeylan, additional, Alharbi, Aisha, additional, Vishwakarma, Ramesh, additional, Albekairy, Abdulkareem, additional, Alkathiri, Abdulmalik, additional, Alanazi, Faisal, additional, Almujarri, Ghada, additional, Alobathani, Seba, additional, Alharbi, Yazeed, additional, Zowawi, Hosam M., additional, and Badreldin, Hisham A., additional

Published
2021
Full Text
View/download PDF

98. The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy Section

Author

Alhazzani, Waleed, primary, Alshahrani, Mohammed, additional, Alshamsi, Fayez, additional, Aljuhani, Ohoud, additional, Eljaaly, Khalid, additional, Hashim, Samaher, additional, Alqahtani, Rakan, additional, Alsaleh, Doaa, additional, Duhailib, Zainab Al, additional, Algethamy, Haifa, additional, Al-Musawi, Tariq, additional, Alshammari, Thamir, additional, Alqarni, Abdullah, additional, Khoujah, Danya, additional, Tashkandi, Wail, additional, Dahhan, Talal, additional, Almutairi, Najla, additional, Alserehi, Haleema A., additional, Al-Yahya, Maytha, additional, Al-Judaibi, Bandar, additional, Arabi, Yaseen M, additional, Abualenain, Jameel, additional, Alotaibi, Jawaher M., additional, Albshabshe, Ali, additional, Alharbi, Reham, additional, Al-Hameed, Fahad, additional, Elhazmi, Alyaa, additional, Almaghrabi, Reem S., additional, Almaghlouth, Fatma, additional, Abedalthagafi, Malak, additional, Khathlan, Noor Al, additional, Al-Suwaidan, Faisal A., additional, Bunyan, Reem F., additional, Baw, Bandar, additional, Alghamdi, Ghassan, additional, Hazmi, Manal Al, additional, Mandourah, Yasser, additional, Assiri, Abdullah, additional, Enani, Mushira, additional, Alawi, Maha, additional, Aljindan, Reem, additional, Aljabbary, Ahmed, additional, Alrbiaan, Abdullah, additional, Algurashi, Fahd, additional, Alsaawi, Abdulmohsen, additional, Alenazi, Thamer H., additional, Alsultan, Mohammed A., additional, Alqahtani, Saleh A., additional, Memish, Ziad, additional, Al-Tawfiq, Jaffar A., additional, and Al-Jedai, Ahmed, additional

Published
2021
Full Text
View/download PDF

99. Additional file 1 of Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study

Author

Al Sulaiman, Khalid, Aljuhani, Ohoud, Al Shaya, Abdulrahman I., Kharbosh, Abdullah, Kensara, Raed, Al Guwairy, Alhomaidi, Alharbi, Aisha, Algarni, Rahmah, Al Harbi, Shmeylan, Vishwakarma, Ramesh, and Korayem, Ghazwa B.

Abstract

Additional file 1: Table e1 Patients Baseline characteristics before and after propensity-score matching.

Published
2021
Full Text
View/download PDF

100. sj-docx-1-jicm-10.1177_08850666211053548 - Supplemental material for The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study

Author

Al Sulaiman, Khalid, Aljuhani, Ohoud, Al Aamer, Kholoud, Al Shaya, Omar, Al Shaya, Abdulrahman, Alsaeedi, Alawi S., Alhubaishi, Alaa, Altebainawi, Ali F., Al Harthi, Alaa, Albelwi, Shorouq, Almutairi, Rahaf, Alsubaie, Norah, Alsallum, Alanoud, Korayem, Ghazwa B., Alfahed, Amjaad, Kensara, Raed, Altebainawi, Elaf F., Alenezi, Raghdah S., Alsulaiman, Thamer, Al Enazi, Huda, Vishwakarma, Ramesh, Al Dabbagh, Tarek, Bakhsh, Umar, and Al Ghamdi, Ghassan

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110305 Emergency Medicine
Abstract

Supplemental material, sj-docx-1-jicm-10.1177_08850666211053548 for The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study by Khalid Al Sulaiman, Ohoud Aljuhani, Kholoud Al Aamer, Omar Al Shaya, Abdulrahman Al Shaya, Alawi S. Alsaeedi, Alaa Alhubaishi, Ali F. Altebainawi, Alaa Al Harthi, Shorouq Albelwi, Rahaf Almutairi, Norah Alsubaie, Alanoud Alsallum, Ghazwa B. Korayem, Amjaad Alfahed, Raed Kensara, Elaf F. Altebainawi, Raghdah S. Alenezi, Thamer Alsulaiman, Huda Al Enazi, Ramesh Vishwakarma, Tarek Al Dabbagh, Umar Bakhsh and Ghassan Al Ghamdi in Journal of Intensive Care Medicine

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results